Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 1
2011 2
2012 2
2013 4
2014 2
2016 2
2017 5
2018 11
2019 4
2020 5
2021 2
2022 3
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Results by year

Filters applied: . Clear all
Page 1
Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates.
Simoni Y, Becht E, Fehlings M, Loh CY, Koo SL, Teng KWW, Yeong JPS, Nahar R, Zhang T, Kared H, Duan K, Ang N, Poidinger M, Lee YY, Larbi A, Khng AJ, Tan E, Fu C, Mathew R, Teo M, Lim WT, Toh CK, Ong BH, Koh T, Hillmer AM, Takano A, Lim TKH, Tan EH, Zhai W, Tan DSW, Tan IB, Newell EW. Simoni Y, et al. Nature. 2018 May;557(7706):575-579. doi: 10.1038/s41586-018-0130-2. Epub 2018 May 16. Nature. 2018. PMID: 29769722
NY-ESO-1-specific redirected T cells with endogenous TCR knockdown mediate tumor response and cytokine release syndrome.
Ishihara M, Kitano S, Kageyama S, Miyahara Y, Yamamoto N, Kato H, Mishima H, Hattori H, Funakoshi T, Kojima T, Sasada T, Sato E, Okamoto S, Tomura D, Nukaya I, Chono H, Mineno J, Kairi MF, Diem Hoang Nguyen P, Simoni Y, Nardin A, Newell E, Fehlings M, Ikeda H, Watanabe T, Shiku H. Ishihara M, et al. Among authors: simoni y. J Immunother Cancer. 2022 Jun;10(6):e003811. doi: 10.1136/jitc-2021-003811. J Immunother Cancer. 2022. PMID: 35768164 Free PMC article. Clinical Trial.
Bystander CD4+ T cells infiltrate human tumors and are phenotypically distinct.
Li S, Zhuang S, Heit A, Koo SL, Tan AC, Chow IT, Kwok WW, Tan IB, Tan DSW, Simoni Y, Newell EW. Li S, et al. Among authors: simoni y. Oncoimmunology. 2022 Jan 2;11(1):2012961. doi: 10.1080/2162402X.2021.2012961. eCollection 2022. Oncoimmunology. 2022. PMID: 36524209 Free PMC article.
Innate immunity in type 1 diabetes.
Diana J, Gahzarian L, Simoni Y, Lehuen A. Diana J, et al. Among authors: simoni y. Discov Med. 2011 Jun;11(61):513-20. Discov Med. 2011. PMID: 21712017 Free article. Review.
Prevention or acceleration of type 1 diabetes by viruses.
Ghazarian L, Diana J, Simoni Y, Beaudoin L, Lehuen A. Ghazarian L, et al. Among authors: simoni y. Cell Mol Life Sci. 2013 Jan;70(2):239-55. doi: 10.1007/s00018-012-1042-1. Epub 2012 Jul 6. Cell Mol Life Sci. 2013. PMID: 22766971 Review.
Intratumoral CD39+CD8+ T Cells Predict Response to Programmed Cell Death Protein-1 or Programmed Death Ligand-1 Blockade in Patients With NSCLC.
Yeong J, Suteja L, Simoni Y, Lau KW, Tan AC, Li HH, Lim S, Loh JH, Wee FYT, Nerurkar SN, Takano A, Tan EH, Lim TKH, Newell EW, Tan DSW. Yeong J, et al. Among authors: simoni y. J Thorac Oncol. 2021 Aug;16(8):1349-1358. doi: 10.1016/j.jtho.2021.04.016. Epub 2021 May 8. J Thorac Oncol. 2021. PMID: 33975004 Free article.
38 results